Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maksim Chelushkin

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancer Cell|August 9, 2022
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomesAleksandr Zaitsev, Maksim Chelushkin, Daniiar Dyikanov, et al.
Nature Cancer|April 10, 2023
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trialLeonie Voorwerk, Olga I Isaeva, Hugo M Horlings, et al.
Nature Medicine|September 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trialIris Nederlof, Olga I Isaeva, Manon de Graaf, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancer Cell|August 9, 2022
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomesAleksandr Zaitsev, Maksim Chelushkin, Daniiar Dyikanov, et al.
Nature Cancer|April 10, 2023
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trialLeonie Voorwerk, Olga I Isaeva, Hugo M Horlings, et al.
Nature Medicine|September 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trialIris Nederlof, Olga I Isaeva, Manon de Graaf, et al.
Pageof 1